Biokinetica Early Phase Institute is a rapidly growing international network of specialised clinical pharmacology sites with a Head Office in Berlin. Our experienced and dedicated clinical study team has over 20 years’ experience in Early Phase drug development. We assist our clients in implementing their strategies through our unique combination of scientific, regulatory and clinical expertise. Our flexible approach helps control risk and delivers superior quality and performance to every customer.